Hunterbrook Media released a short report on diabetes-focused DexCom Inc. DXCM, citing that the company sold the "adulterated" device.Benzinga reached out to DexCom for comments and is yet to hear from them.A surprise FDA inspection found Dexcom made an unauthorized design change to the G7 glucose monitoring device, with internal tests showing worse accuracy across the board.Despite this, the company sold the device, drawing FDA scrutiny. Executives have since departed as patient complaints climbed, rivals ...